Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Vensana in the News

Vensana in the News

Eight VCs Join NVCA Board and Barry Eggers of Lightspeed Appointed Chair

Vensana in the News

Vensana—Is Medtech Investing on the Rebound?

Vensana in the News

Medtech investor duo seeks to ‘fill the gap’ in device sector private funding

Vensana in the News

New Minnesota-based fund has $225 million to invest in young med-tech companies

Vensana in the News

New med-tech investment firm Vensana Capital launches $225 million fund

Vensana in the News

Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund

Vensana in the News

Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty

Vensana in the News

New Medtech Investor Vensana Closes $225 Million Debut Fund

Vensana in the News

Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana

Vensana in the News

Medical Device Investors Form New Medtech Venture Firm

17

Novel FDA PMA & de novo 510k approvals

37

U.S. Commercial Product Launches

34

Level I Clinical Trials

23

Strategic Financings

25

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together?

Get in Touch

Our Latest

See All News
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
Resources
News LP Access
Contact
info@vensanacap.com 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2019 Vensana Capital Management, LLC | Privacy | Terms & Conditions